































Cells are continuously exposed to a wide variety of 
physical and chemical stresses such as oxidation, 
radiation and heavy metals, which cause damage to 
cellular proteins, lipids and DNA. Organisms have 
evolved multiple protective mechanisms to counteract 
these endogenous and exogenous damages. Never-
theless, the effectiveness of these protective pathways 
seems to decline with age. As such, aging can be 
defined as the decrease in the probability of successful 
repair of cellular damage. 
 
One of the major sources of cellular insults is damage to 
DNA. To counteract detrimental DNA damage, cells are 
endowed with a complex network of DNA damage 
response (DDR) proteins which are capable of detecting 
DNA damage, and then triggering and amplifying a 
signaling cascade, which ultimately leads to either cell-
cycle arrest and DNA repair, or to apoptotic cell death 
to eliminate permanently damaged cells [1]. The 
importance of the DDR in maintaining genomic 
integrity and limiting the effects of aging is highlighted 
































DNA repair factors [2]. More tellingly, almost all 
genetic conditions that lead to premature aging in 
humans have been mapped to genes belonging to the 
DDR [3]. Mutations in the Werner DNA helicase, 
which is required for DNA replication and at telomeres, 
lead to Werner syndrome and the components of the 
nucleotide excision repair (NER) XPC, ERCC6, 
ERCC8 and the ERCC1/XPF complex involved in 
inter-strand DNA crosslink repair are mutated in 
Cockayne Syndrome and in Trichothiodystrophy 
(TTD), two prominent premature aging disorders [4]. 
These findings suggest a prominent, and causal, role for 
DNA damage responses in aging. 
 
The DDR, like all major nuclear processes such as DNA 
replication and transcription, operates in the context of 
the chromatin fiber [5, 6]. Chromatin is made up of 
nucleosomes, repetitive units of 146bp of DNA tightly 
wrapped around an octameric core of histone proteins 
(H2A, H2B, H3 and H4). Nucleosomes are further 
packaged into higher order structures by the action of 
architectural chromatin proteins such as histone H1 and 
heterochromatin protein HP1.  Based on cytological 
criteria, chromatin is classified into euchromatin, which 
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and into heterochromatin, which is more compacted and 
generally represents a transcriptionally repressive 
environment. Nucleosomal histones are modified by 
complex patterns of post-translational modifications 
(PTM) such as acetylation, methylation and ubiquitina-
tion which appear to dictate the dynamic recruitment of 
non-histone proteins to chromatin and regulate its 
function [7]. Furthermore, chromatin structure and 
function is also determined by the methylation status of 
DNA itself and by a large number of ATP-dependent 
remodeling factors. Both the level of chromatin 
compaction, and hence the accessibility of DNA, and the 
recruitment of chromatin-associated factors determine the 
outcome of transcription, DNA replication and DNA 
damage repair. All these modifications to chromatin 
structure, and thus its informational content, are inherited 
through several cycles of cell division and as such 
represent an epigenetic memory [8].  
 
Chromatin defects in aging 
 
Chromatin defects are associated with aging. The first 
hints pointing to a possible link between chromatin 
maintenance and aging came from studies in the yeast 
S. cerevesiae, where the NADH-dependent Sir2 histone 
deacetylase Sir2 was found to be important for 
establishing heterochromatin at telomeres, at ribosomal 
DNA (rDNA), and at HMR and HMR loci, which 
encode factors needed for yeast mating type switching 
[9-14]. Upon prolonged growth, equated to aging in 
yeast, repetitive rDNA tends to hyper-recombine and 
form extrachromosomal rDNA circles (ERC), indicative 
of increased chromatin fragility [15]. Formation of 
heterochromatin at rDNA sites by overexpression of 
Sir2 reduces this hyper-recombination and prolongs 
lifespan, suggesting a contribution of chromatin 
structure to aging [16]. Further experiments in worms 
and flies demonstrated a similar role in lifespan 
extension for Sirt1, the closest orthologue of yeast Sir2 
in these organisms [17, 18]. Nevertheless, the role of 
Sirt1 in increased longevity in higher eukaryotes might 
not just involve heterochromatin maintenance, since in 
this case the molecular mechanism does not seem to 
involve ERC stabilization [19]. Furthermore, the 
analysis is complicated by the fact that in mammals 
SIRT1 deacetylates a wide variety of non-histone, 
aging-related transcription factors such as p53, HSF1 
and members of the FOXO transcription factors family 
[20-22]. Identification of the mechanisms of action of 
SIRT1 in higher organisms will be key to clarifying its 
role in the aging process.  
 
There are several other clear indications for a role  of  
chromatin and its maintenance in aging. A hallmark of 
cellular aging is the appearance of characteristic 
changes in the epigenetic make-up of the genome.   
Epigenetic changes associated with aging in mammalian 
cells include loss of DNA methylation at repetitive 
DNA sequences [23-25], which are generally hetero-
chromatinized, and an increase in DNA methylation at 
CpG islands in the promoters of specific genes [26, 27]. 
Cells from aged individuals and patients with the 
premature aging disorder Hutchinson-Gilford Progeria 
Syndrome (HGPS) are also characterized by loss of 
heterochromatin, by loss of key architectural chromatin 
proteins such as HP1 and the histone mehtyltransferase 
EZH2, and, importantly, by alterations in the levels of 
heterochromatin-associated histone PTM including 
H3K9me3 and H3K27me3 [28-31]. Interestingly, both 
prematurely and normally aged cells exhibit drama-
tically increased levels of unrepaired DNA damage [30, 
32]. 
 
In addition to epigenetic and structural chromatin 
defects, there are indications that aging in mammals is 
accompanied by stochastic deregulation of gene 
expression.  Transcriptional noise at the single cell level 
increases with age in the mouse heart, most likely as a 
consequence of oxidative DNA damage [33]. 
Furthermore, in mammalian cells oxidative DNA 
damage also seems to relocalize SIRT1 from otherwise 
transcriptionally repressed genes to sites of DNA 
damage [34]. This has led to the speculation that, 
through unknown mechanisms, aging disrupts the 
epigenetic organization of heterochromatin both at a 
global and at a gene-specific level, thus leading to 
elevation of stochastic transcriptional noise and to the 
disruption of transcriptional programs necessary for 
proper cell homeostasis [35]. In contrast to this model 
of stochastically occurring defects in gene expression 
programs, the aging process seems to also induce a 
specific transcriptional response, which dampens the 
somatotrophic IGF-1 axis and helps protecting cells 
from DNA damage and stress [36]. 
 
The study of chromatin in aging also points to a key 
influence of aberrant chromatin structure on aging-
related defects in DNA repair. Impairment of SIRT1 
leads to defective DNA damage repair in mammalian 
cells [34] and a knock-out mouse model for SIRT6 
shows signs of premature aging and has defects in the 
base excision repair pathway [37]. The exact molecular 
basis for these phenotypes is not clear yet. One 
possibility is that SIRT6 affects genomic stability by 
regulating the levels of H3K56Ac [38, 39], a PTM 
important for chromatin assembly and DNA damage 




www.impactaging.com                  1018                                   AGING, December 2009, Vol.1 No.12A molecular mechanism for aging-associated 
chromatin defects 
 
The molecular mechanisms leading to chromatin defects 
in aging are largely unknown. Recent analysis of 
chromatin defects in the premature aging disease HGPS 
have given some of the first insights into how chromatin 
ages [42]. HGPS is an extremely rare genetic disease 
caused by a de novo point mutation in the lamin A 
(LMNA) gene, a major structural component of the 
nuclear envelope [43].The pathogenic mutation leads to 
the production of an internally truncated form of lamin 
A, referred to as progerin. This protein acts in a 
dominant-negative gain of function fashion causing the 
diverse and pronounced chromatin defects. Analysis of 
the molecular mechanisms involved in bringing about 
chromatin defects in HGPS and old cells uncovered the 
NURD complex as a key player in aging [42]. NURD is 
a ubiquitous chromatin remodeling complex which 
contains the histone deacetylases HDAC1 and HDAC2 
and the ATPases CHD3 and CHD4 as catalytic 
subunits. NURD has been implicated in transcriptional 
repression at specific promoters and more recently has 
also been shown to associate with pericentromeric 
heterochromatin [44, 45]. The protein levels and the 
activity of several NURD components including 
HDAC1 and the histone chaperones RBBP4/, are 
reduced in HGPS cells and normally aged cells. A direct 
role for NURD loss in aging-associated chromatin 
defects is indicated by the finding that knock-down of 
NURD members in normal cells recapitulates aging-
related chromatin defects including heterochromatin 
loss and increased DNA damage [42]. NURD is known 
to be involved in a variety of chromatin functions and 
its loss may explain the broad spectrum of chromatin 
defects seen in aged cells [42].  
 
Chromatin structure as a trigger of aging 
 
There is little doubt that chromatin defects and DNA 
damage play a part in the aging process. The unresolved 
question is: how? One recently proposed scenario 
suggests that DNA damage and the cellular response to 
it leads to chromatin defects via relocation of epigenetic 
machinery from its normal distribution in the genome 
and to structural chromatin changes, eventually 
resulting in gene misregulation [34] (Figure 1A). An 
alternative possibility is that the aging process is 
triggered by loss of chromatin structure, leading to 
altered epigenetic modifications, and increased 
susceptibility to DNA damage. In this model DNA 
damage is a downstream event (Figure 1B). The key 
question to distinguish between these two models is: 
what comes first, DNA damage or chromatin defects? A 
partial answer comes from recent observations in the 
premature aging disorder HGPS. Upon induction of the 
dominant negative disease-causing protein in normal 
skin fibroblasts, chromatin defects occurred prior to 
DNA damage [42]. Further support for a trigger role of 
chromatin structure in DNA damage and aging, is the 
observation that suppression of the activity of chromatin 
modifiers generates high levels of endogenous DNA 
damage, as seen in the case of several subunits of the 
NURD complex [42], the SET8 H4K20 histone 
methylase [46, 47], and for the Su(var)3-9 H3K9 
histone methylase in Drosophila  [48]. In these cases 
chromatin structural defects clearly precede DNA 
damage, placing epigenetic and chroma-tin structure 












































which  chromatin  structure  acts  as  a  causal  trigger  for  aging.
Feedback  loops,  which  are  likely  to  exist  between  most
individual events, are not shown for simplicity.  (C) Chromatin
structure  and  DNA  damage  pathways  act  in  an  integrated
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damage and aging? Although only poorly investigated 
and understood, it is becoming clear that chromatin 
structure affects the susceptibility of DNA to damage 
and progression of the DDR [5]. DNA repair occurs 
with slower kinetics in highly condensed hetero-
chromatin, presumably due to the inability of repair 
factors to rapidly access the site of damage [49]. 
Furthermore, heterochromatinized regions of the 
genome, like nucleoli, centromeres and telomeres tend 
to be rich in repetitive sequences that are particularly 
prone to recombination. As such it is possible that the 
compacted nature of heterochromatin suppresses hyper-
recombination of repetitive sequences, the formation of 
aberrant DNA structures and genomic instability [50]. 
Another, not-mutually exclusive, possibility is that 
altered chromatin structure increases the steady-state 
level of DNA damage due to replication defects such as 
impaired passage of the replication machinery or to 
replication fork stalling. It is indeed possible that intact 
heterochromatin conformation is necessary for the DNA 
replication machinery to properly proceed through 
highly repetitive portions of the genome. This last 
hypothesis is in line with the observation that siRNA 
silencing of either the histone-chaperones RBBP4/7 
[42] or of SET8 [46, 47] impairs S-phase progression.  
 
Although these observations point towards an upstream 
role of chromatin structure in determining DNA 
stability, it is also true that genome integrity influences 
chromatin structure. Local DNA damage affects the 
epigenetic status of chromatin both in the vicinity of a 
lesion through phosphorylation, acetylation and 
ubiquitination of nearby histones, but also globally [51]. 
In response to local DNA damage, the zinc finger 
protein KAP1 is phosporylated by the ATM kinase and 
released from heterochromatin, thus facilitating the 
access of DNA repair factors to these more compacted 
regions of the genome and also potentially altering 
chromatin structure at other sites [51]. Furthermore, as 
previously mentioned, DNA damage results in 
redistribution of chromatin associated factors and 
histone modifiers like SIRT1, possibly leading to 
profound changes in the transcriptional regulation of 
genes [34]. Clearly, the relationship between chromatin 
structure and DNA damage is not unidirectional, but 
rather a mutual one. 
 
A network of aging mechanisms 
 
In our search of molecular mechanisms for biological 
processes we usually look for linear pathways. What we 
are learning about the interplay between chromatin 
structure, epigenetic regulation and DNA repair makes 
it clear that this is not a one-way street and that these 
processes are likely connected and linked by feedback 
mechanisms. The most likely scenario is that chromatin 
structure, epigenetic status, and DNA repair represent 
nodes of a network of processes involved in protecting  
cells from endogenous and exogenous insults, 
ultimately leading to increased longevity (Figure 1C). 
Importantly, these processes do not work in isolation, 
but instead are linked to pathways dedicated to maintain 
proteostasis such as the heat shock response or 
autophagy, and hormonal regulation of cellular growth, 
with the mTOR and IGF-1 pathways, whose role in the 
regulation of longevity has already been established in 
mammals [52-54]. In support of a branched network of 
cellular functions involved in aging, possible 
connections between the DNA damage, the inhibition of 
the IGF-I and mTOR pathways have been suggested 
[55]. This scenario is supported by observations in cells 
from the ZMPSTE24-/- mouse, a murine model of 
HGPS in which lamin A processing is impaired. The 
progeriod ZEMPSTE24-/- mouse shows dramatic 
alterations in heterochromatin architecture, 
accompanied by increased DNA damage, by the 
activation of the authophagic response and by 
downregulation of the mTOR pathway [32, 56].  
 
Aging is a complex process. It is hardly realistic for it to 
be explained by a single pathway or even a set of 
closely related pathways. More likely, many diverse 
cellular functions will contribute to aging and they will 
do so in a highly inter-dependent manner. The recent 
investigation of the role of chromatin structure, 
epigenetic modifications and DNA damage in aging 
makes this clear. While we are still struggling to 
understand the precise relationship of these events in the 
aging process, we are already discovering links to more 
distantly related events such as signaling pathways and 
metabolism.  Rather than attempting to explain aging as 
the consequence of degeneration of single pathways, a 
conceptual framework consisting of a network of 
affected processes not only reconciles different, at times 
contentious hypotheses regarding aging mechanisms, 
but will ultimately lead to an integrated view of these 
processes and to a more accurate understanding of the 
molecular basis of aging.  
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